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ABSTRACT
INTRODUCTION: Dry eye disease (DED) and ocular allergy are common conditions in the eye practice. 
They have more than 20% of prevalence and that fact increases healthcare problems and affects life quality. 
Rheumatologic diseases such as Sjogren’s syndrome (SS) are often associated with ophthalmic findings, and 
belong to the dry eye but with decreased tear film production.
MATERIAL AND METHODS: The laser-scanning confocal microscopy (LSCM) was performed to 16 eyes 
of 8 patients with subjective complains and objective clinical signs of DED and SS. The results of examina-
tions were compared with control group of 28 eyes of 14 healthy patients. The qualitative analysis was per-
formed to calculate the cell density in all cornea layers. The presence and distribution of Langerhans cells 
(LCs) in cornea was estimated. The quantitative survey understood monitoring of inflammation signs and 
corneal changes such as a presence of leukocytes. Changes in subbasal nerve plexus (SNP) and Meibomian 
glands (MGs) were evaluated over time.
RESULTS: The quantitative analysis presented calculations of cell density of all cornea layers. The most im-
portant finding was the reduction of epithelium cell density. In healthy patients it was 5048.6±56 cells/mm2 
compared to 4603±70 cells/mm2 in DED-SS patients, but also the keratocyte number was significantly low-
er. The density of corneal LCs was compared to the healthy patients: 71±8 cells/mm2 and 19±3cells/mm2 re-
spectively. The quantitative observation showed visible changes in SNP especially in tortuosity and destiny 
of sub-basal nerves.
CONCLUSION: The ability of LSCM technology to examine different components of the ocular surface 
has opened new doors for studying the physiology and pathology. LSCM allows understanding the patho-
logical changes of DED and SS. Our study proved that these diseases affect all structures of the anterior oc-
ular surface.
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INTRODUCTION
Dry eye disease (DED) and ocular allergy are 
common problem often underdiagnosed in the eye 
care practice. They are ones of the leading reasons 
for patient’s visits to ophthalmologists. DED and al-
lergy have more than 20% of prevalence and that fact 
increases healthcare problems and affects life quali-
ty (1-4). DED includes a broad spectrum of signs and 
symptoms that make classification very complex.
Rheumatologic diseases are often associated 
with ophthalmic findings, particularly diseases re-
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lated with dry eye and the ocular surface. Sjögren’s 
syndrome (SS) is a chronic autoimmune disease in 
which white blood cells destroy the exocrine glands, 
especially salivary and lacrimal glands. It is a group 
of diseases overseen by rheumatologists but its man-
agement requires more specialty areas: rheumatolo-
gy, ophthalmology and oral medicine (5,6,7). 
The DED and SS have different pathogenic 
mechanisms. Their clinical differences are not al-
ways as clear-cut as expected. The cause is a com-
mon inflammatory involvement of the same ocular 
surface structure (epithelium of cornea and conjunc-
tiva) (1). The high-tech diagnostic instruments are 
rapidly becoming important additional tools for cor-
rect management of these diseases.
In vivo laser-scanning confocal microscopy 
(LSCM) is an emerging noninvasive technology that 
allows exploring eye surface structures at the cellular 
level. The provided images are comparable to known 
methods of histology without affecting the steady 
state of observed tissues (1,7). The most suitable ocu-
lar surface issues to be studied by LSCM are cell net, 
innervation, Meibomian glands and inflammation 
changes (1,8).  
The purpose of this work is to evaluate the 
changes of ocular surface and to present the distribu-
tion of Langerhans cells (LCs) in cornea of patients 
with DED and SS by in vivo laser-scanning confocal 
microscopy and to define the markers of inflamma-
tory reaction.
MATERIALS AND METHODS
The LSCM was performed to 16 eyes of 8 pa-
tients (all subjects were female, mean age 48.2±8.9 
years) with subjective complains and objective clin-
ical signs of DED and laboratory proved SS. The re-
sults of the examinations were compared with the re-
sults of the control group of 28 eyes of 14 healthy pa-
tients (all female, mean age 30.5±5.4 years). All sub-
jects underwent slip-lamp examination to determine 
their clinical status. The qualitative analysis was per-
formed to calculate the cell density in all cornea lay-
ers. The presence and distribution of Langerhans 
cells (LCs) in cornea was estimated. The quantita-
tive survey understood monitoring of inflammation 
signs and corneal changes such as a presence of leu-
kocytes. Changes in subbasal nerve plexus (SNP) and 
Meibomian glands (MGs) were also followed in this 
study.
LSCM application to the cornea provided new 
important information about changes in this avas-
cular, thin and transparent, and multilayered tissue 
(1). LSCM was performed on all subjects with a new 
generation confocal microscope, the Rostock Corne-
al Software Version 1.2 of the HRTIII-RCM (Heidel-
berg Retina Tomograph III - Rostock Cornea Mod-
ule, Heidelberg Engineering GmbH, Germany), 
based on a diode laser with a 670nm wavelength. Gel 
(Corneregel, Bausch&Lomb GmbH, Berlin, Germa-
ny) was used as a coupling agent between the appla-
nating lens cap and objective lens.
After the eye was anaesthezed (Alcain, o,5% 
collyr, Alcon) the Tomo-Cap was positioned onto the 
center of the cornea or onto the palpebral conjunc-
tiva of the averted eyelid by adjusting the controller, 
and the digital images of the corneal layers or under-
lying Meibomian glands (MGs) were observed on the 
computer screen. 
The examination started when the first su-
perficial cells were visualized. The digital microm-
eter gauge was set at zero, and then by pressing on 
the foot pedal, sequence images were recorded by 
a charge-coupled device camera (maximum 30 
frames/s) while gradually moving the focal plane 
into the explored tissue until the structures were vi-
sualized. The length of a single confocal microsco-
py examination session was approximately 10 min. 
None of the subjects complained of discomfort nor 
any adverse effects were observed as a consequence 
of the examination. 
RESULTS
The quantitative analysis presented calcula-
tions of cell density of all cornea layers. The most im-
portant finding was the reduction of epithelium cell 
density. In healthy patients it was 5048.6±56 cells/
mm2 compared to 4603±70 cells/mm2 in DED-SS pa-
tients, but also the keratocyte number was signifi-
cantly lower. The results are presented in number of 
cells in mm2 (Table 1). Using LSCM there was a vis-
ible structural difference between healthy and DED-
SS corneas (Fig. 1).
The presence and distribution of Langerhans 
cells (LCs) in cornea was estimated in order to dem-
onstrate an inflammatory reaction. The most sig-
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nificant change in DED and SS patients is the in-
creased density of corneal LCs or dendric cells com-
pared to the healthy patients group: 71±8 cells/mm2 
compared to 19±3cells/mm2. On attentive quantita-
tive observation a difference on SNP is visible. The 
most frequent findings are in tortuosity and desti-
ny of sub-basal nerves (Fig. 2). In vivo confocal as-
sessment of inflammatory cells in stroma present-
ed among small hyper-reflective cells were probably 
leukocytes. These cells were also found around the 
Healthy patients  
(cells/mm2 )
DED and Sjogren syndrome  
patients (cells/mm2 )
Epithelium 5048.6±56 4603±70
Anterior stroma 288.40±43 112±12
Posterior stroma 251.20±39 150±13
Endothelium 2848.20±108 2532±102
Table 1. Quantitative data for all cornea layers in healthy and DED-SS patients
Fig. 1. Quantitative imaging by LSCM of healthy and DED-SS corneas 
1-healthy cornea and 2-cornea of dry eye disease and Sjogren syndrome patient: 
a) epithelium; b) subbasal nerve plexus; c) anterior stroma; d) posterior stroma; e) endothelium;
Fig. 2. LSCM demonstrating Langerhans cells in healthy and DED-SS patients
a) In healthy patients: normal structure
b) and c) DED-SS patients: decreased subbasal nerve density and increased tortuosity, high level of Langerhans cells 
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Meibomian glands (MGs). The later showed chang-
es in their normal anatomic structure such as fully or 
partly obstruction of glands’ lumens and accumula-
tion of Meibum into gland lumen (Fig. 3). The acinar 
diameter and orifice diameter were increased.
DISCUSSION
The disease of dry eye is complex, multifacto-
rial ocular surface disease, involving the eye like a 
morphofunctional unit (1). This system integrated 
the tear film, lacrimal glands, cornea, conjunctiva, 
Meibomian glands, lids, and the sensory and motor 
nerves (10).
Recently, comparison of in vivo LSCM data 
for patients with primary SS, non-Sjogren dry eye 
disease and control individuals showed significant 
changes related with DED clinical signs regarding 
densities of corneal epithelias (1,9). Villani et al. in an 
elegant study demonstrated that all cornea in range 
of DED values vs. controls, as it is shown 941–1506 
vs. 1902 cells/mm2 presented a decreased superficial 
epithelial cell density. The densities of basal epithelial 
were also decreased (3616–4875 vs. 5164 cells/mm2) 
respectively (1,11).
Previous other confocal findings partly con-
firmed and led the hypothesis that changes on the 
epithelium and especially difference in cell density 
are consequential indicators for tissue damage (1,12). 
Other in vivo LSCM studies provided several partial-
ly validated parameters which included dendric cells 
(DCs), presumed leukocytes and activated kerato-
cytes (9,11,12). In our study we encounter a signifi-
cantly decreased number of basal epithelial cells, as 
well as a decreased number of stromal keratocytes. 
This is another confirmation of the destructive effect 
of the dry eye on the anterior ocular surface.
Originally described by Engelmann in 1867 
(7,13), DCs are antigen-presenting cells of bone mar-
row origin: the current concept is that corneal epithe-
lial DCs are identical to the immunologically active 
LCs of the epidermis. The presence and distribution 
of LCs in the central cornea is an issue of ongoing 
discussion: some investigators have already shown 
the presence of LCs in patients with herpes keratitis 
(7,14) and in contact lens wearers and in healthy vol-
unteers (15,16) by using confocal microscopy. 
An Italian research group, Machetta et al., 
gave also the mean values of LCs density calculat-
ed in central corneas and peripheral corneas of three 
groups: SS, non-SS DED and healthy patients. There 
was a difference in LCs distribution: an increasing 
cell number from the center to the periphery of the 
cornea, but this trend difference between LCs den-
sity in these two corneal areas was significant only 
in normal subjects. LCs density in central cornea of 
DED-SS patients was calculated to 55.55 cells/mm2 
and 29.89 cells/mm2 in healthy subjects. The density 
in peripheral cornea was 66.66 cells/mm2 and 35.29 
cells/mm2 in healthy ones (5). In our studies we had 
a significantly increased number of DCs in patients 
Fig. 3. LSCM demonstrating Meibomian glands
a) normal MGs
b) MGs and inflammatory cells around
c) normal healthy MGs’ structure
d) lack of connective tissue
e) normal gland orifice
f) increased gland diameter and partly obstructed lumen
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with SS in comparison to normal subjects. This ad-
vanced difference might be a result of the severity of 
the disease in all included patients. 
The conjuctival densities of cells presumed to 
be leukocytes have elevated in all SS, non –SS DED 
and DED patients (87 vs. 177-498 cells/mm2) com-
pared to healthy subjects (1,9,11). In vivo LSCM as-
sessment of “presumed leukocytes” has recently been 
partially validated in tarsal and bulbar conjuncti-
vas (1,12,17). Ibrahim et al. quantified presumed MG 
leukocyte density. They reported that as a MG and 
DED disease diagnostic tool (1). The density of leu-
kocytes was 100% for both sensitivity and specificity 
with a cut-off at 300 cells/mm2 (18).
The hyper-reflective stromal cells were identi-
fied in confocal reports (1). They were presumed to 
be activated keratocytes. They were not histological-
ly described, and could be interpreted in more than 
one way (1,9,12,19). These cells could be understood 
as normal stromal cells in which the light from the 
confocal microscope ray strikes at an unusual angle. 
These changes were associated to cornea inflamma-
tion in DED patients (1,9,12) or Graves’ orbitopathy. 
But they could be also normal stromal cells. Howev-
er, they might be cells that disappear during the tis-
sue processing, or change their shape. Future clinical 
and pathological correlations are definitely required 
to improve our understanding.
Corneal nerves are involved in the maintenance 
of ocular surface homeostasis playing a key trophic 
role and also regulating secretion and distribution of 
tears (1,11). The cornea is the most densely innervat-
ed tissue in the body, and is a main player in DED. 
LSCM allows the description of the morphology, 
density, and disease-induced alterations of corneal 
nerves, particularly the sub-basal nerve plexus (1,8).
Villani et al., comparing SS, non-SS DED, DED, 
and healthy individuals, found that DED patients 
had decreased numbers of nerves (2.9–4.3 vs. 5.8 n/
frame), and increased tortuosity (1.5–2.5 vs. 1.2, grad-
ing 1–4) and bead-like formations (218–304 vs. 116 
n/100 mm) (1,9). More recently, Labbe et al. (20) re-
ported decreased nerve density (9.426 vs. 15.956mm/
mm2) and number (24.73 vs. 39.06 n/mm2), which 
is supposed to be related with DED. They did not 
describe significant nerve tortuosity and beading 
changes (1,20). Recently, there are several small stud-
ies that quantitated and analyzed morphologic SNP 
changes (1,12). They found partially conflicting data 
(1,12). As visible from our results we confirm these 
observations. 
About MGs in DED and SS patients recent con-
focal studies of team of Milan confirmed increased 
acinar diameters (94–106 vs. 49–53mm) and orifice 
diameters (48–50 vs. 32–35mm), increased secre-
tion reflectivity, and decreased acinar unit density 
(57–64 vs. 110–121n/mm2) in MG Disease (MGD) (1, 
11). The results were compared with these of healthy 
patients.
Ibrahim et al. first validated the confocal pa-
rameters of MG acinar longest diameter, acinar 
shortest diameter, and acinar unit density for the di-
agnosis of MGD (1,18). The primary SS patients have 
less obvious interpretation; they showed persistence 
of inflammation signs, but without morphologic 
changes. That led to the hypothesis of an inflamma-
tory–atrophic nonobstructive MGD (1,12,21). We en-
countered bright, round cells presumed to be inflam-
matory cells in all tested eyes and believe that this is 
firm evidence that although primary affecting lacri-
mal secretory glands SS has a severe impact on the 
MGs as well. That explains the severity of symptoms 
and signs confirming the advance of the disease.
CONCLUSION
The ability of LSCM technology to examine dif-
ferent components of the ocular surface has opened 
new doors for studying the physiology and patholo-
gy. LSCM allows the understanding of the patholog-
ical changes of DED and SS corneas and the assess-
ment of prognosis and treatment as well. Our study 
proved that DED and SS affect all structures of the 
anterior ocular surface.
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